Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.45 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.45 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.45 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.45 |
| ▸ | PRKDC | P78527 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ERN1 | O75460 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29447325 | 1.00 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2GRIA1GRIA2GRIA3 | |
| SCHEMBL548760 | 0.91 | GRIA1 (0.45) | ALDH1A1SMN1; SMN2GRIA1GRIA2GRIA3 | |
| SCHEMBL2884919 | 0.84 | GRIA1 (0.56) | ALDH1A1SMN1; SMN2GRIA1GRIA2GRIA3 | |
| SCHEMBL10018128 | 0.83 | PRKDC (0.54) | ALDH1A1SMN1; SMN2GRIA1GRIA2GRIA3 | |
| SCHEMBL15920680 | 0.82 | KDM1A (0.43) | ALDH1A1SMN1; SMN2GRIA1GRIA2GRIA3 | |
| SCHEMBL21822946 | 0.80 | ERN1 (0.48) | ALDH1A1PRKDCTSHRERN1LMNA | |
| SCHEMBL850513 | 0.80 | PRKDC (0.38) | ALDH1A1SMN1; SMN2GRIA1GRIA2GRIA3 | |
| SCHEMBL29979076 | 0.80 | TDP1 (0.42) | ALDH1A1SMN1; SMN2GRIA1GRIA2GRIA3 | |
| SCHEMBL31028601 | 0.80 | PRKDC (0.38) | ALDH1A1SMN1; SMN2GRIA1GRIA2GRIA3 | |
| SCHEMBL22660158 | 0.80 | ERN1 (0.41) | ALDH1A1SMN1; SMN2GRIA1GRIA2GRIA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022094-A1 | Compounds for the Treatment of Neurodegenerative Diseases | CELGENE CORPORATION (US) | 2026-01-22 | — | — | US | disclosed |
| WO-2024019957-A1 | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | CELGENE CORPORATION (US) | 2024-01-25 | — | — | WO | disclosed |
| WO-2024019957-A1 | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | CELGENE CORPORATION (US) | 2024-01-25 | — | — | WO | disclosed |
| US-20230331675-A1 | AROMATIC ETHYLENE COMPOUND AND PREPARATION METHOD THEREFOR, AND INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF | GUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD. (CN) | 2023-10-19 | — | — | US | disclosed |
| US-20230331675-A1 | AROMATIC ETHYLENE COMPOUND AND PREPARATION METHOD THEREFOR, AND INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF | GUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD. (CN) | 2023-10-19 | — | — | US | disclosed |
| EP-4212511-A1 | AROMATIC ETHYLENE COMPOUND AND PREPARATION METHOD THEREFOR, AND INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF | Guangzhou Maxinovel Pharmaceuticals Co., Ltd. (CN) | 2023-07-19 | — | — | EP | disclosed |
| WO-2022052926-A1 | AROMATIC ETHYLENE COMPOUND AND PREPARATION METHOD THEREFOR, AND INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF | 广州再极医药科技有限公司 | 2022-03-17 | — | — | WO | disclosed |
| US-20210386721-A1 | SUBSTITUTED PHENYLPROPENYL PYRIDINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL APPLICATIONS | SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2021-12-16 | — | — | US | disclosed |
| CN-112566905-A | Substituted phenyl propenyl pyridine derivatives, preparation method and medical application thereof | 上海海雁医药科技有限公司 | 2021-03-26 | — | — | CN | disclosed |
| WO-2020228649-A1 | SUBSTITUTED PHENYLPROPENYLPYRIDINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 上海海雁医药科技有限公司 | 2020-11-19 | — | — | WO | disclosed |
| WO-2014094357-A1 | HETEROCYCLIC NUCLEAR HORMONE RECEPTOR MODULATORS | ABBVIE INC. (US) | 2014-06-26 | — | — | WO | disclosed |
| US-8525131-B2 | Phosphorescent organic compounds | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2013-09-03 | — | — | US | disclosed |
| US-20120248337-A1 | PHOSPHORESCENT ORGANIC COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2012-10-04 | — | — | US | disclosed |
| EP-1969651-B1 | SENSITIZING COMPLEXES, THEIR METHOD OF PRODUCTION, HYBRID INORGANIC/ ORGANIC SEMICONDUCTOR MATERIAL COMPRISING THEM, AND PHOTOVOLTAIC CELL COMPRISING THIS MATERIAL | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2009-09-16 | — | — | EP | disclosed |
| US-20080276985-A1 | Sensitizing Complexes, Process For The Preparation Thereof, Semiconductive Inorganic/Organic Hybrid Material Comprising Them, And Photovoltaic Cell Comprising Said Material | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2008-11-13 | — | — | US | disclosed |
| EP-1969651-A1 | SENSITIZING COMPLEXES, THEIR METHOD OF PRODUCTION, HYBRID INORGANIC/ ORGANIC SEMICONDUCTOR MATERIAL COMPRISING THEM, AND PHOTOVOLTAIC CELL COMPRISING THIS MATERIAL | Commissariat à l'Energie Atomique (FR) | 2008-09-17 | — | — | EP | disclosed |
| US-20070299114-A1 | Biaryl Derivatives | SHIONOGI & CO., LTD. (JP) | 2007-12-27 | — | — | US | disclosed |
| US-20070299114-A1 | Biaryl Derivatives | SHIONOGI & CO., LTD. (JP) | 2007-12-27 | — | — | US | disclosed |
| WO-2007071792-A1 | SENSITIZING COMPLEXES, THEIR METHOD OF PRODUCTION, HYBRID INORGANIC/ ORGANIC SEMICONDUCTOR MATERIAL COMPRISING THEM, AND PHOTOVOLTAIC CELL COMPRISING THIS MATERIAL | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2007-06-28 | — | — | WO | disclosed |
| EP-1798224-A1 | BIARYL DERIVATIVE | Shionogi Co., Ltd. (JP) | 2007-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070299114-A1 | Biaryl Derivatives | CBR3, NR1H4, CBR1 | ALDH1A1 2267/4885SMN1; SMN2 3914/4885GRIA1 283/4885 |
| US-20120248337-A1 | PHOSPHORESCENT ORGANIC COMPOUNDS | PAICS, PPIP5K2, PPA1 | ALDH1A1 2605/4885SMN1; SMN2 2370/4885GRIA1 3170/4885 |
| US-20210386721-A1 | SUBSTITUTED PHENYLPROPENYL PYRIDINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL APPLICATIONS | PDCD1, CD274, PDCD1LG2 | ALDH1A1 26/4885SMN1; SMN2 3068/4885GRIA1 1396/4885 |
| US-20260022094-A1 | Compounds for the Treatment of Neurodegenerative Diseases | S1PR5, CLN6, S1PR1 | ALDH1A1 1518/4885SMN1; SMN2 37/4885GRIA1 1071/4885 |
| US-20230331675-A1 | AROMATIC ETHYLENE COMPOUND AND PREPARATION METHOD THEREFOR, AND INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF | PDCD1, CD274, PDCD1LG2 | ALDH1A1 243/4885SMN1; SMN2 3728/4885GRIA1 1980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.